Psyence Biomedical Ltd. (PBM)
NASDAQ: PBM · Real-Time Price · USD
4.210
-0.100 (-2.32%)
Aug 28, 2026, 4:00 PM EDT - Market closed
Psyence Biomedical Market Cap
Psyence Biomedical has a market cap or net worth of $16.06 million as of August 28, 2026. Its market cap has increased by 785.27% in one year.
Market Cap
16.06M
Enterprise Value
8.61M
1-Year Change
785.27%
Ranking
Category
Stock Price
$4.21
ChartMarket Cap Chart
Since December 10, 2021, Psyence Biomedical's market cap has decreased from $323.44M to $16.06M, a decrease of -95.04%. That is a compound annual growth rate of -47.08%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 16.06M | 1,038.56% |
| Dec 31, 2025 | 1.41M | -84.90% |
| Dec 31, 2024 | 9.34M | -88.49% |
| Dec 29, 2023 | 81.16M | -75.84% |
| Dec 30, 2022 | 335.86M | 3.73% |
| Dec 31, 2021 | 323.77M | 0.10% |
| Dec 10, 2021 | 323.44M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BioCardia | 17.41M |
| Palatin Technologies | 17.33M |
| Lexaria Bioscience | 17.10M |
| Tempest Therapeutics | 16.94M |
| Citius Pharmaceuticals | 16.53M |
| Pluri | 16.51M |
| BioVie | 16.29M |
| AEON Biopharma | 15.67M |